Press Releases

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008

November 30, 2015

Astellas and Ironwood Report Positive Top-Line Data from Phase III IBS-C Trial Conducted in Japan

November 30, 2015

Ironwood Reports Positive Top-Line Data from Phase II Trial of Linaclotide in Adult Patients With Opioid-Induced Constipation

November 4, 2015

Ironwood Pharmaceuticals to Present at Credit Suisse 24th Annual Healthcare Conference

November 3, 2015

Ironwood Pharmaceuticals Provides Third Quarter 2015 Investor Update

November 3, 2015

Ironwood Pharmaceuticals Initiates Clinical Studies of Soluble Guanylate Cyclase Stimulators IW-1973 and IW-1701

November 2, 2015

Ironwood and Allergan Initiate Phase IIb Clinical Trial of Linaclotide Colonic Release in Adults with Irritable Bowel Syndrome with Constipation

October 27, 2015

Allergan Acquires Rights To Ironwood's CONSTELLA® (Linaclotide) From Almirall In More Than 40 Countries

October 19, 2015

Ironwood Highlights Refractory GERD and Constipation Research at the American College of Gastroenterology 2015 Annual Scientific Meeting

October 14, 2015

Ironwood Pharmaceuticals to Host Third Quarter 2015 Investor Update Call

October 13, 2015

Ironwood Reports Positive Top-Line Results from Phase III Trial of 72 mcg Linaclotide in Adults with Chronic Idiopathic Constipation

September 10, 2015

Ironwood Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference

August 5, 2015

Ironwood Pharmaceuticals Provides Second Quarter 2015 Investor Update

August 5, 2015

Ironwood and Allergan Enter Agreement to Co-Promote VIBERZI for Irritable Bowel Syndrome with Diarrhea (IBS-D) in the U.S.

July 22, 2015

Ironwood Progresses sGC Stimulator Platform with Positive Top-Line Phase I Data on IW-1973

July 15, 2015

Ironwood Pharmaceuticals to Host Second Quarter 2015 Investor Update Call

July 8, 2015

AstraZeneca and Ironwood Report Positive Top-Line Data from Phase III IBS-C Trial Designed to Support Linaclotide Approval in China

June 10, 2015

Ironwood Pharmaceuticals Prices $300 Million of Convertible Senior Notes

June 8, 2015

Ironwood Pharmaceuticals Announces Proposed Offering of $300 Million of Convertible Senior Notes

June 4, 2015

Ironwood Pharmaceuticals to Present at Goldman Sachs 36th Annual Global Healthcare Conference

May 13, 2015

Ironwood Presents Gastrointestinal Disease Research at Digestive Disease Week® 2015

May 7, 2015

Ironwood Pharmaceuticals to Present at Bank of America Merrill Lynch 2015 Health Care Conference

May 5, 2015

Ironwood Pharmaceuticals Provides First Quarter 2015 Investor Update

April 16, 2015

Ironwood Pharmaceuticals Appoints Lawrence Olanoff, M.D., Ph.D., to Board of Directors

April 15, 2015

Ironwood Pharmaceuticals to Host First Quarter 2015 Investor Update Call

March 9, 2015

Exact Sciences and Ironwood Pharmaceuticals Enter Co-Promotion Agreement for Cologuard®

March 5, 2015

Ironwood Pharmaceuticals Initiates Phase I Clinical Study of sGC Stimulator IW-1973

March 4, 2015

Ironwood Pharmaceuticals to Present at Barclays Global Healthcare Conference

February 23, 2015

Ironwood Pharmaceuticals to Present at Cowen and Company 35th Annual Health Care Conference

February 12, 2015

Ironwood Pharmaceuticals Provides Fourth Quarter 2014 Investor Update

February 4, 2015

Ironwood Reports Positive Top-Line Data from Exploratory Phase IIa Trial Of IW-3718 in Refractory Gastroesophageal Reflux Disease

January 29, 2015

Ironwood Pharmaceuticals to Host Fourth Quarter 2014 Investor Update Call

January 5, 2015

Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference